Rainer Strohmenger

Rainer Strohmenger is a prominent figure in the life sciences investment sector, serving as a Board Member at Advanced Medical Balloons and a Managing Partner at Wellington Partners. His extensive experience spans over 25 years in venture capital, particularly focused on innovative life science companies across Europe.

Professional Background

• Education: Rainer holds a doctorate in medicine and a Master of Science in economics, both from Ludwig-Maximilians-University in Munich, Germany. He also received training at the Entrepreneurship Center of MIT in Boston, USA.

• Venture Capital Experience: Since joining Wellington Partners in 1997, he has been instrumental in managing investments that have led to six IPOs and numerous successful trade sales, including notable companies like Actelion and Oxford Immunotec.12 His portfolio includes over 25 investments in biotech, medtech, diagnostics, and digital health sectors.

• Board Memberships: In addition to his role at Advanced Medical Balloons, Rainer serves on the boards of several other companies, including Aignostics and Adrenomed AG. He is also involved with eGenesis as a board observer.24

Contributions to the Industry

Rainer's contributions to the industry are significant; he has facilitated substantial investments that have advanced medical technologies and treatments. His leadership at Wellington Partners has positioned the firm as a key player in the European venture capital landscape for life sciences.13

In summary, Rainer Strohmenger's expertise in venture capital and his commitment to fostering innovation in healthcare make him a valuable asset to Advanced Medical Balloons and the broader medical investment community.